Target intelligence / Profile preview

Heat shock protein X (HspX)

Target
HspX
Molecular classification
Small heat shock protein, Molecular chaperone, Alpha-crystallin family
01

Overview

Heat shock protein X (HspX), also known as the 16 kDa antigen or alpha-crystallin-like protein (Acr), is a small heat shock protein produced by Mycobacterium tuberculosis. It is encoded by the Rv2031c gene and functions as a molecular chaperone that prevents protein aggregation and maintains proteostasis under stress conditions such as hypoxia and nitric oxide exposure. HspX is highly upregulated during the stationary growth phase and is a hallmark of the latent stage of tuberculosis infection, where it plays a critical role in slowing bacterial growth to facilitate long-term persistence within host macrophages. Because of its central role in mycobacterial dormancy, HspX is considered a promising therapeutic target for drugs intended to shorten tuberculosis treatment and prevent disease relapse. Additionally, HspX is a major immunodominant antigen being utilized in the development of diagnostic biomarkers for latent infection and as a candidate for subunit vaccines to boost the efficacy of the BCG vaccine.

Other names
16 kDa antigenAlpha-crystallin-like proteinAcrRv2031cHsp16.3Dormancy-related proteinSmall heat shock protein X
02

Mechanism of action

Inhibition of chaperone activity to prevent bacterial dormancy and sensitize latent bacilli to antibiotics; Immunostimulation as a subunit vaccine component to enhance Th1-mediated protection.

03

Biological functions

Chaperone activityProtein foldingBacterial growth regulationResponse to hypoxiaVirulenceImmunomodulationSurvival in macrophages
04

Disease associations

TuberculosisLatent tuberculosis infectionAllergic asthmaSarcoidosis
05

Safety considerations

Cross-reactivity with antigens from other mycobacterial species (e.g., M. bovis, environmental mycobacteria)Potential for bacterial hypervirulence if growth-slowing mechanisms are dysregulatedTherapeutic challenge of targeting metabolically inactive latent bacteria
06

Biomarkers

Anti-HspX IgG antibodiesAnti-HspX IgM antibodiesHspX protein (serum)IFN-gamma (T-cell response to HspX)

Beyond the preview

Go deeper on Heat shock protein X (HspX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein X (HspX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call